Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis
Author:
Affiliation:
1. Division of Hematology/Oncology, Department of Oncology; Karmanos Cancer Institute, Wayne State University; Detroit Michigan
Funder
U.S. Department of Health and Human Services
NIH Clinical Center
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31738/fullpdf
Reference29 articles.
1. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia;Hamblin;Blood,1999
2. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med,2000
3. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile;Wiestner;Blood,2003
4. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia;Damle;Blood,1999
5. Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens;Thompson;Cancer,2015
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study;Cancers;2023-08-10
2. Expert consensus on the management of chronic lymphocytic leukaemia in Asia;Clinical and Experimental Medicine;2023-02-16
3. Patterns of use of biological and genetic markers for chronic lymphocytic leukemia and acute myeloid leukemia in Puerto Rico;Cancer Medicine;2022-11-25
4. Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status;Advances in Therapy;2022-05-24
5. Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal—Results from a population-based cancer registry cohort study;PLOS ONE;2021-10-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3